Tru-Scint AD monoclonal antibody kit: Will begin this fall a Phase II/III trial in 150 patients, with enrollment to take one year. A pharmacokinetic and dosing

Biomira Inc. (BIOMF), Edmonton, Alberta

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.